
Lulit Semunegus
Examiner (ID: 260)
| Most Active Art Unit | 3641 |
| Art Unit(s) | 3641 |
| Total Applications | 322 |
| Issued Applications | 269 |
| Pending Applications | 18 |
| Abandoned Applications | 35 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15175259
[patent_doc_number] => 20190358221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => OPIOID AGONIST / ANTAGONIST COMBINATION DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 16/477268
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/477268 | Opioid agonist / antagonist combination dosage forms | Jan 11, 2018 | Issued |
Array
(
[id] => 12723871
[patent_doc_number] => 20180133124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => BODY CARE PRODUCT CONTAINING POROUS SILVER PARTICLES
[patent_app_type] => utility
[patent_app_number] => 15/869734
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15869734
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/869734 | BODY CARE PRODUCT CONTAINING POROUS SILVER PARTICLES | Jan 11, 2018 | Abandoned |
Array
(
[id] => 15360599
[patent_doc_number] => 20200016064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => COLOURANT-INCORPORATED SILK FOR VALUE-ADDED COSMETICS
[patent_app_type] => utility
[patent_app_number] => 16/469118
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469118
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469118 | COLOURANT-INCORPORATED SILK FOR VALUE-ADDED COSMETICS | Dec 19, 2017 | Abandoned |
Array
(
[id] => 12637134
[patent_doc_number] => 20180104208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME
[patent_app_type] => utility
[patent_app_number] => 15/842194
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15842194
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/842194 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME | Dec 13, 2017 | Abandoned |
Array
(
[id] => 15585979
[patent_doc_number] => 20200069524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => A METHOD TO RELIEVE STRESS IN CAPSULE SHELLS TO REDUCE PROPENSITY TO BREAK
[patent_app_type] => utility
[patent_app_number] => 16/467408
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467408
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467408 | Method to relieve stress in capsule shells to reduce propensity to break | Dec 7, 2017 | Issued |
Array
(
[id] => 12603825
[patent_doc_number] => 20180093105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => PHOTOTHERMAL NANOSTRUCTURES IN TUMOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/819284
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15819284
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/819284 | PHOTOTHERMAL NANOSTRUCTURES IN TUMOR THERAPY | Nov 20, 2017 | Abandoned |
Array
(
[id] => 12997397
[patent_doc_number] => 10022344
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Liquid dosage forms of sodium naproxen
[patent_app_type] => utility
[patent_app_number] => 15/817471
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3945
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15817471
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/817471 | Liquid dosage forms of sodium naproxen | Nov 19, 2017 | Issued |
Array
(
[id] => 15524497
[patent_doc_number] => 20200054554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => EMULSION EYEDROPS
[patent_app_type] => utility
[patent_app_number] => 16/348538
[patent_app_country] => US
[patent_app_date] => 2017-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348538
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348538 | Emulsion eyedrops | Nov 15, 2017 | Issued |
Array
(
[id] => 16197301
[patent_doc_number] => 10722437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Cosmetic agents with "improved protection against body odor"
[patent_app_type] => utility
[patent_app_number] => 15/807588
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8792
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15807588
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/807588 | Cosmetic agents with "improved protection against body odor" | Nov 8, 2017 | Issued |
Array
(
[id] => 17937131
[patent_doc_number] => 11471563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Preparing method of nerve conduits
[patent_app_type] => utility
[patent_app_number] => 15/796988
[patent_app_country] => US
[patent_app_date] => 2017-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 7961
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 270
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796988
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/796988 | Preparing method of nerve conduits | Oct 29, 2017 | Issued |
Array
(
[id] => 12217411
[patent_doc_number] => 20180055770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/DMPG, LYSOPG AND LYSOPC AGAINST DRUGS THAT CAUSE CHANNELOPATHIES'
[patent_app_type] => utility
[patent_app_number] => 15/788683
[patent_app_country] => US
[patent_app_date] => 2017-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11635
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15788683
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/788683 | Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies | Oct 18, 2017 | Issued |
Array
(
[id] => 15492865
[patent_doc_number] => 20200046621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => ORAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/342748
[patent_app_country] => US
[patent_app_date] => 2017-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16342748
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/342748 | ORAL COMPOSITION | Oct 16, 2017 | Abandoned |
Array
(
[id] => 12675265
[patent_doc_number] => 20180116921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => ANTIPERSPIRANT COMPOSITION WITH IMPROVED SKIN FEELING
[patent_app_type] => utility
[patent_app_number] => 15/784208
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15784208
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/784208 | ANTIPERSPIRANT COMPOSITION WITH IMPROVED SKIN FEELING | Oct 15, 2017 | Abandoned |
Array
(
[id] => 12723943
[patent_doc_number] => 20180133148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => Degradable Microparticles for Protein and Small Molecule Delivery
[patent_app_type] => utility
[patent_app_number] => 15/782388
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782388
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/782388 | Degradable Microparticles for Protein and Small Molecule Delivery | Oct 11, 2017 | Abandoned |
Array
(
[id] => 15450955
[patent_doc_number] => 20200038301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => COSMETIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/339158
[patent_app_country] => US
[patent_app_date] => 2017-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339158
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339158 | COSMETIC COMPOSITIONS | Oct 8, 2017 | Abandoned |
Array
(
[id] => 12601593
[patent_doc_number] => 20180092361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => INSECTICIDAL COMPOSITION AND METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 15/725068
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15725068
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/725068 | INSECTICIDAL COMPOSITION AND METHOD OF USE | Oct 3, 2017 | Abandoned |
Array
(
[id] => 16726391
[patent_doc_number] => 20210093538
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-04-01
[patent_title] => Keratin Treatments
[patent_app_type] => utility
[patent_app_number] => 15/721988
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721988
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721988 | Keratin Treatments | Oct 1, 2017 | Abandoned |
Array
(
[id] => 16726391
[patent_doc_number] => 20210093538
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-04-01
[patent_title] => Keratin Treatments
[patent_app_type] => utility
[patent_app_number] => 15/721988
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721988
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721988 | Keratin Treatments | Oct 1, 2017 | Abandoned |
Array
(
[id] => 15405129
[patent_doc_number] => 20200022886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => LOW DENSITY, STABLE FOAM FOR TOPICAL APPLICATION
[patent_app_type] => utility
[patent_app_number] => 16/337968
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337968
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337968 | LOW DENSITY, STABLE FOAM FOR TOPICAL APPLICATION | Sep 27, 2017 | Abandoned |
Array
(
[id] => 16138851
[patent_doc_number] => 10702479
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Pharmaceutical formulation comprising sembragiline
[patent_app_type] => utility
[patent_app_number] => 15/715638
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2767
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15715638
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/715638 | Pharmaceutical formulation comprising sembragiline | Sep 25, 2017 | Issued |